VistaGen Receives Notice of Allowance for Canadian Patent Further Expanding … – MarketWatch
|
VistaGen Receives Notice of Allowance for Canadian Patent Further Expanding …
MarketWatch SOUTH SAN FRANCISCO, CA, Aug 19, 2014 (Marketwired via COMTEX) — VistaGen Therapeutics, Inc. (otcqb:VSTAD), a biotechnology company applying pluripotent stem cell technology for drug rescue, drug discovery and regenerative medicine, today … |
